跳至主要内容
临床试验/TCTR20210304001
TCTR20210304001尚未招募4 期

Effects of Curcumin on Improving Mild Cognitive Impairment in Adults and Elderly Subjects with Metabolic Syndrome: A Randomized Controlled Trial

Faculty of Medicine, Chiang Mai University0 个研究点目标入组 150 人开始时间: 2021年3月4日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
45 Years 至 75 Years(—)
性别
All

入选标准

  • Metabolic syndrome patients with mild cognitive impairment
  • Age 45-75 years old

排除标准

  • 1. Prior diagnosis of dementia or positive screening for dementia
  • 2. Having depression
  • 3. Recent infected or anti-biotic use within 4 weeks
  • 4. Recent surgery less than 3 months
  • 5. Chronic kidney disease stage 4 and 5
  • 6. Having cancer with active treatment or autoimmune disease
  • 7. Allergy to curcumin
  • 8. Abnormal liver function test

研究者

相似试验

Effects of Curcumin on Improving Mild Cognitive... | 临床试验